#
1
CARDIOVASCULAR
BACK
Our webinar series focus on the wholistic management of cardiac patients for cardiology, EP and heart failure fellows.
Most live webinars are available on-demand shortly after they air. So, you’ll never miss an opportunity to learn from cardiology experts.
This program, sponsored by Abbott, has been designed for all levels of fellows in training. Today, managing and treating the cardiac patient involves more than just looking at EKGs, echocardiograms and utilizing cutting-edge medical technology. The modern Cardiologist must also consider the economics of medicine. During this innovative presentation, we will explore transitioning from fellow to attending from both the fellow’s and the onboarding institution’s perspective. This thought-provoking webinar has been designed to reduce the learning curve of fellows advancing into their practice as an attending, while keeping employer’s expectations in mind.
This is part three of the four-part series. Renal Failure and Kidney Disease are common comorbidities that can have serious ramifications on the cardiology patient’s prognosis and quality of life. The treatment of many cardiovascular conditions can negatively affect renal health and vice versa. The safe and effective management of kidney failure is dependent upon close collaboration between Cardiology and Nephrology.
This program, sponsored by Abbott, has been designed to bridge existing knowledge gaps to fulfill unmet clinical and procedural needs related to the treatment of mitral valve disease, utilizing MitraClip. Due to the degenerative complexity and sophisticated progressive nature of mitral valve disease, medical management and/or surgical corrections do not always produce the best possible patient outcomes. The COAPT trial shines great clarity on best practices in patient selection criteria, short and long term clinical outcomes, and impact on patients with pre-existing/developing heart failure. Dr. James Hermiller, who has been a key thought leader and pioneer in managing these multifaceted patients, will share his clinical insights into the data produced by the COAPT trial. He will also speak from his experience on which patients he believes stand to benefit the most from the option of MitraClip therapy. This dynamic, interactive, and highly educational event has been developed to enhance the learning experience and professional growth for physicians, fellows, and staff of all levels.
This is part two of the four-part series. Sleep Apnea is one of the most common comorbidities for cardiology patients today. Sleep Apnea can be a predictor and contributor for many cardiac conditions and appropriate treatment can greatly reduce complications of cardiovascular patients. This comprehensive, thought-provoking program has been designed to enhance clinical care and efficient patient co-management while discussing how to guide the care of your patient as part of a multidisciplinary team.
This is part one of the four-part series. Diabetes is a chronic disease that plagues many cardiology patients. This discussion will address working alongside our Endocrinology partners in managing this complex patient.
This unique, thought-provoking program for all levels of cardiology fellows has been designed to enhance clinical care and efficient patient co-management while discussing how to guide the care of your patient in conjunction with sub specialty partners.
This is part four of the four-part series. Hypertension has long been known as the silent killer. Consistently elevated blood pressure wreaks havoc on the human body and, if left untreated or undertreated, can lead to death. Hypertension is likely one of the first items listed in your patient’s medical history. Effective management of hypertension for cardiac patients is imperative to favorable patient outcomes.
This program, sponsored by Abbott, has been designed for all levels of fellows in training. Today, managing and treating the cardiac patient involves more than just looking at EKGs, echocardiograms and utilizing cutting-edge medical technology. The modern Cardiologist must also consider the economics of medicine. During this innovative presentation, we will explore transitioning from fellow to attending from both the fellow’s and the onboarding institution’s perspective. This thought-provoking webinar has been designed to reduce the learning curve of fellows advancing into their practice as an attending, while keeping employer’s expectations in mind.
This program, sponsored by Abbott, has been designed to bridge existing knowledge gaps to fulfill unmet clinical and procedural needs related to the management of HFrEF patients, utilizing CRT technologies. Since the introduction of CRT therapy over 25 years ago, there have been many advancements in the devices, leads, and algorithms to treat this cohort of challenging patients. John Rickard, M.D., who has been a key thought leader and pioneer in managing these multifaceted patients, will share his clinical insights on optimizing these devices in order to enhance patient outcomes. He will present how various device and lead technologies, as well as new algorithms, can improve the effectiveness of patient therapy. This dynamic and interactive event has been developed to enhance the learning experience and professional growth for physicians, fellows, and staff of all levels.
In this webinar, Dr. Amin Al-Ahmad will speak from his extensive experience to explain his approach to managing recurrent and persistent AF patients. We will learn what leads to identifying the need for a repeat AF ablation as well as his ablation strategy, mapping technique, and distinct differences over the initial procedure.
This program, sponsored by Abbott, has been designed for all levels of fellows in training. Today, managing and treating the cardiac patient involves more than just looking at EKGs, echocardiograms and utilizing cutting-edge medical technology. The modern Cardiologist must also consider the economics of medicine. During this innovative presentation, we will explore transitioning from fellow to attending from both the fellow’s and the onboarding institution’s perspective. This thought-provoking webinar has been designed to reduce the learning curve of fellows advancing into their practice as an attending, while keeping employer’s expectations in mind.
This program, sponsored by Abbott, has been designed to bridge existing knowledge gaps to fulfill unmet clinical and procedural needs related to the management of HFrEF patients, utilizing CRT technologies. Since the introduction of CRT therapy over 25 years ago, there have been many advancements in the devices, leads, and algorithms to treat this cohort of challenging patients. John Rickard, M.D., who has been a key thought leader and pioneer in managing these multifaceted patients, will share his clinical insights on optimizing these devices in order to enhance patient outcomes. He will present how various device and lead technologies, as well as new algorithms, can improve the effectiveness of patient therapy. This dynamic and interactive event has been developed to enhance the learning experience and professional growth for physicians, fellows, and staff of all levels.
This educational program will address knowledge gaps related to heart failure management for advanced heart failure patients. At the end of the program, participants will have a greater understanding of how to optimize medical and device therapy for patients across the full spectrum of heart failure, integrating emerging technologies for remote monitoring and mechanical circulatory support.
This program, sponsored by Abbott, has been designed to bridge existing knowledge gaps to fulfill unmet clinical and procedural needs related to the treatment of mitral valve disease, utilizing MitraClip. Due to the degenerative complexity and sophisticated progressive nature of mitral valve disease, medical management and/or surgical corrections do not always produce the best possible patient outcomes. The COAPT trial shines great clarity on best practices in patient selection criteria, short and long term clinical outcomes, and impact on patients with pre-existing/developing heart failure. Dr. James Hermiller, who has been a key thought leader and pioneer in managing these multifaceted patients, will share his clinical insights into the data produced by the COAPT trial. He will also speak from his experience on which patients he believes stand to benefit the most from the option of MitraClip therapy. This dynamic, interactive, and highly educational event has been developed to enhance the learning experience and professional growth for physicians, fellows, and staff of all levels.
MAT-1900230 v3.0
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test